Back to Search
Start Over
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
- Source :
-
Journal of the National Cancer Institute [J Natl Cancer Inst] 2012 Mar 07; Vol. 104 (5), pp. 406-14. Date of Electronic Publication: 2012 Jan 16. - Publication Year :
- 2012
-
Abstract
- Background: The association between black race and worse outcomes in operable breast cancer reported in previous studies has been attributed to a higher incidence of more aggressive triple-negative disease, disparities in care, and comorbidities. We evaluated associations between black race and outcomes, by tumor hormone receptor and HER2 expression, in patients who were treated with contemporary adjuvant therapy.<br />Methods: The effect of black race on disease-free and overall survival was evaluated using Cox proportional hazards models adjusted for multiple covariates in a clinical trial population that was treated with anthracycline- and taxane-containing chemotherapy. Categorical variables were compared using the Fisher exact test. All P values are two-sided.<br />Results: Of 4817 eligible patients, 405 (8.4%) were black. Compared with nonblack patients, black patients had a higher rate of triple-negative disease (31.9% vs 17.2%; P < .001) and a higher body mass index (median: 31.7 vs 27.4 kg/m(2); P < .001). Black race was statistically significantly associated with worse disease-free survival (5-year disease-free survival, black vs nonblack: 76.7% vs 84.5%; hazard ratio of recurrence or death = 1.58, 95% confidence interval = 1.19 to 2.10, P = .0015) and overall survival (5-year overall survival, black vs nonblack: 87.6% vs 91.9%; hazard ratio of death = 1.49, 95% confidence interval = 1.05 to 2.12, P = .025) in patients with hormone receptor-positive HER2-negative disease but not in patients with triple-negative or HER2-positive disease. In a model that included black race, hormone receptor-positive HER2-negative disease vs other subtypes, and their interaction, the interaction term was statistically significant for disease-free survival (P = .027) but not for overall survival (P = .086).<br />Conclusion: Factors other than disparities in care or aggressive disease contribute to increased recurrence in black women with hormone receptor-positive breast cancer.
- Subjects :
- Adult
Aged
Aged, 80 and over
Breast Neoplasms chemistry
Breast Neoplasms drug therapy
Breast Neoplasms mortality
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Healthcare Disparities
Humans
Kaplan-Meier Estimate
Mastectomy methods
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local diagnosis
Neoplasm Recurrence, Local prevention & control
Neoplasm Staging
Odds Ratio
Randomized Controlled Trials as Topic
Receptor, ErbB-2 analysis
Receptors, Estrogen analysis
Receptors, Progesterone analysis
Retrospective Studies
Risk Factors
Survival Analysis
Taxoids administration & dosage
Treatment Outcome
United States epidemiology
Black or African American statistics & numerical data
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor analysis
Breast Neoplasms ethnology
Breast Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2105
- Volume :
- 104
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of the National Cancer Institute
- Publication Type :
- Academic Journal
- Accession number :
- 22250182
- Full Text :
- https://doi.org/10.1093/jnci/djr543